Compare TPR & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TPR | RMD |
|---|---|---|
| Founded | 1941 | 1989 |
| Country | United States | United States |
| Employees | N/A | 10600 |
| Industry | Apparel | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.3B | 28.4B |
| IPO Year | 2000 | N/A |
| Metric | TPR | RMD |
|---|---|---|
| Price | $152.40 | $211.53 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 10 |
| Target Price | $145.44 | ★ $292.56 |
| AVG Volume (30 Days) | ★ 1.8M | 1.3M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | 1.13% | ★ 1.13% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.58 | N/A |
| Revenue | ★ $5,880,000,000.00 | N/A |
| Revenue This Year | $12.39 | $10.60 |
| Revenue Next Year | $5.36 | $7.41 |
| P/E Ratio | $27.29 | ★ $25.61 |
| Revenue Growth | ★ 31.01 | N/A |
| 52 Week Low | $92.62 | $180.27 |
| 52 Week High | $161.97 | $293.81 |
| Indicator | TPR | RMD |
|---|---|---|
| Relative Strength Index (RSI) | 61.55 | 57.00 |
| Support Level | $149.64 | $198.63 |
| Resistance Level | $157.02 | $211.74 |
| Average True Range (ATR) | 4.28 | 5.20 |
| MACD | 1.32 | 1.35 |
| Stochastic Oscillator | 86.67 | 76.99 |
Based in New York City, Tapestry is the parent company of accessories and fashion brand Coach, which accounted for 80% of its revenue and well over 90% of its operating profit in fiscal 2025. Handbags accounted for 58% of the brand's fiscal 2025 revenue. Coach products are sold through more than 950 company-owned stores, company-operated digital channels, and wholesale partners in North America, Asia, and Europe. Tapestry also owns Kate Spade (17% of fiscal 2025 revenue), which operates about 335 worldwide stores and generated 52% of its sales from handbags in fiscal 2025. Kate Spade is known for its colorful patterns and graphics. Tapestry sold its smallest brand, luxury footwear maker Stuart Weitzman, to Caleres in August 2025.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.